AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival
Authors: Giles, FJ Shen, Y Kantarjian, HM Korbling, MJ O'Brien, S Anderlini, P Donato, M Pierce, S Keating, MJ Freireich, EJ Estey, E
Citation: Fj. Giles et al., Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival, LEUK LYMPH, 42(1-2), 2001, pp. 67-73
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis
Authors: Korbling, M Giralt, S Khouri, I Mirza, N Donato, M Anderlini, P Fischer, H Andreeff, M McMannis, J Champlin, R
Citation: M. Korbling et al., Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis, J CLIN APH, 16(2), 2001, pp. 82-87
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia
Authors: Bibawi, S Abi-Said, D Fayad, L Anderlini, P Ueno, NT Mehra, R Khouri, I Giralt, S Gajewski, J Donato, M Claxton, D Braunschweig, I van Besien, K Andreeff, M Andersson, BS Estey, EH Champlin, R Przepiorka, D
Citation: S. Bibawi et al., Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia, AM J HEMAT, 67(4), 2001, pp. 227-233
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins
Authors: Ghosh, S Champlin, RE Ueno, NT Anderlini, P Rolston, K Raad, I Kontoyiannis, D Jacobson, K Luna, M Tarrand, J Whimbey, E
Citation: S. Ghosh et al., Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins, BONE MAR TR, 28(3), 2001, pp. 271-275
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
Authors: Shimoni, A Smith, TL Aleman, A Weber, D Dimopoulos, M Anderlini, P Andersson, B Claxton, D Ueno, NT Khouri, I Donato, M Korbling, M Alexanian, R Champlin, R Giralt, S
Citation: A. Shimoni et al., Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma, BONE MAR TR, 27(8), 2001, pp. 821-828
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
Authors: Anderlini, P Rizzo, JD Nugent, ML Schmitz, N Champlin, RE Horowitz, MM
Citation: P. Anderlini et al., Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases, BONE MAR TR, 27(7), 2001, pp. 689-692
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
Authors: Champlin, R Khouri, I Anderlini, P Gajewski, J Kornblau, S Molldrem, J Shimoni, A Ueno, N Giralt, S
Citation: R. Champlin et al., Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation, BONE MAR TR, 27, 2001, pp. S13-S22
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study
Authors: Ravandi, F Kantarjian, H Cohen, A Davis, M O'Brien, S Anderlini, P Andersson, B Claxton, D Donato, M Gajewski, J Khouri, I Korbling, M Ueno, N deVos, D Champlin, R Giralt, S
Citation: F. Ravandi et al., Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study, BONE MAR TR, 27(12), 2001, pp. 1221-1225
Mobilized PBPC concentrates: a maturing blood component
Authors: Stroncek, D Anderlini, P
Citation: D. Stroncek et P. Anderlini, Mobilized PBPC concentrates: a maturing blood component, TRANSFUSION, 41(2), 2001, pp. 168-171
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
Authors: Przepiorka, D Anderlini, P Saliba, R Cleary, K Mehra, R Khouri, I Huh, YO Giralt, S Braunschweig, I van Besien, K Champlin, R
Citation: D. Przepiorka et al., Chronic graft-versus-host disease after allogeneic blood stem cell transplantation, BLOOD, 98(6), 2001, pp. 1695-1700
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Authors: Khouri, IF Saliba, RM Giralt, SA Lee, MS Okoroji, GJ Hagemeister, FB Korbling, M Younes, A Ippoliti, C Gajewski, JL McLaughlin, P Anderlini, P Donato, ML Cabanillas, FF Champlin, RE
Citation: If. Khouri et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, BLOOD, 98(13), 2001, pp. 3595-3599
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
Authors: Korbling, M Anderlini, P
Citation: M. Korbling et P. Anderlini, Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?, BLOOD, 98(10), 2001, pp. 2900-2908
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
Authors: Giralt, S Thall, PF Khouri, I Wang, XM Braunschweig, I Ippolitti, C Claxton, D Donato, M Bruton, J Cohen, A Davis, M Andersson, BS Anderlini, P Gajewski, J Kornblau, S Andreeff, M Przepiorka, D Ueno, NT Molldrem, J Champlin, R
Citation: S. Giralt et al., Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation, BLOOD, 97(3), 2001, pp. 631-637
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors
Authors: Przepiorka, D Smith, TL Folloder, J Anderlini, P Chan, KW Korbling, M Lichtiger, B Norfleet, F Champlin, R
Citation: D. Przepiorka et al., Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors, BLOOD, 97(11), 2001, pp. 3405-3410
Tacrolimus does not abrogate the increased risk of acute graft-versus-hostdisease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB I and HLA-DQB I
Authors: Przepiorka, D Saliba, R Cleary, K Fischer, H Tonai, R Fritsche, H Khouri, IF Folloder, J Ueno, NT Mehra, R Ippoliti, C Giralt, S Gajewski, J Donato, M Claxton, D Braunschweig, I van Besien, K Anderlini, P Andersson, BS Champlin, R
Citation: D. Przepiorka et al., Tacrolimus does not abrogate the increased risk of acute graft-versus-hostdisease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB I and HLA-DQB I, BIOL BLOOD, 6(2A), 2000, pp. 190-197
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
Authors: Anderlini, P Giralt, S Andersson, B Ueno, NT Khouri, I Acholonu, S Cohen, A Korbling, MJ Manning, J Romaguera, J Sarris, A Rodriguez, MA Hagemeister, F McLaughlin, P Cabanillas, F Champlin, RE
Citation: P. Anderlini et al., Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease, BONE MAR TR, 26(6), 2000, pp. 615-620
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
Authors: Donato, ML Gershenson, D Ippoliti, C Wharton, JT Bast, RC Aleman, A Anderlini, P Gajewski, JG Giralt, S Molldrem, J Ueno, N Lauppe, J Korbling, M Boyer, J Bodurka-Bevers, D Bevers, M Burke, T Freedman, R Levenback, C Wolf, J Champlin, RE
Citation: Ml. Donato et al., High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer, BONE MAR TR, 25(11), 2000, pp. 1137-1140
Harnessing graft-versus-malignancy: Non-myeloablative preparative regimensfor allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
Authors: Champlin, R Khouri, I Shimoni, A Gajewski, J Kornblau, S Molldrem, J Ueno, N Giralt, S Anderlini, P
Citation: R. Champlin et al., Harnessing graft-versus-malignancy: Non-myeloablative preparative regimensfor allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy, BR J HAEM, 111(1), 2000, pp. 18-29
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34(+) peripheral blood progenitor cells in normal donors
Authors: Anderlini, P Donato, M Lauppe, MJ Huh, YO Martin, TG Chan, KW Champlin, PE Korbling, M
Citation: P. Anderlini et al., A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34(+) peripheral blood progenitor cells in normal donors, BR J HAEM, 109(4), 2000, pp. 770-772
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system
Authors: Przepiorka, D Lu, JG Anderlini, P Korbling, M Donato, M Champlin, R Gee, AP van Vlasselaer, P
Citation: D. Przepiorka et al., Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system, CYTOTHERAPY, 1(2), 1999, pp. 111-117
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma
Authors: Donato, ML Champlin, RE Van Besien, KW Korbling, M Cabanillas, F Anderlini, P Gajewski, JG Lauppe, J Durett, A Andersson, B Giralt, S Khouri, I Hagemeister, F Romaguera, JE Sarris, A McLaughlin, P Younes, A Ippoliti, C Blamble, DA Hester, J Gee, A Rodriguez, MA
Citation: Ml. Donato et al., Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma, LEUK LYMPH, 35(3-4), 1999, pp. 317-324
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
Authors: Przepiorka, D van Besien, K Khouri, I Hagemeister, F Samuels, B Folloder, J Ueno, NT Molldrem, J Mehra, R Korbling, M Giralt, S Gajewski, J Donato, M Cleary, K Claxton, D Braunschweig, I Andersson, B Anderlini, P Champlin, R
Citation: D. Przepiorka et al., Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma, ANN ONCOL, 10(5), 1999, pp. 527-532
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy
Authors: Khouri, IF Lee, MS Romaguera, J Mirza, N Kantarjian, H Korbling, M Albitar, M Giralt, S Samuels, B Anderlini, P Rodriguez, J von Wolff, B Gajewski, J Cabanillas, F Champlin, R
Citation: If. Khouri et al., Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy, ANN ONCOL, 10(11), 1999, pp. 1293-1299
Allogeneic hematopoietic transplantation as adoptive immunotherapy - Induction of graft-versus-malignancy as primary therapy
Authors: Champlin, R Khouri, I Kornblau, S Marini, F Anderlini, P Ueno, NT Molldrem, J Giralt, S
Citation: R. Champlin et al., Allogeneic hematopoietic transplantation as adoptive immunotherapy - Induction of graft-versus-malignancy as primary therapy, HEMAT ONCOL, 13(5), 1999, pp. 1041
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation
Authors: Przepiorka, D Khouri, I Ippoliti, C Ueno, NT Mehra, R Korbling, M Giralt, S Gajewski, J Fischer, H Donato, M Cleary, K Claxton, D Chan, KW Braunschweig, I van Besien, K Andersson, BS Anderlini, P Champlin, R
Citation: D. Przepiorka et al., Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation, BONE MAR TR, 24(7), 1999, pp. 763-768
Risultati: 1-25 | 26-28